ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 11 - 14 of 14
Presenter(s): Angela H Ciccia, PhD, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Pediatric traumatic brain injury (TBI) is a leading cause of acquired disability in childhood, and students with TBI often experience challenges that fall within the SLP scope of practice. This session presents practical information, tips, and strategies that SLPs can use to improve service provision for students with TBI.
Presenter(s): Nicole Cruse, PhD; Nicholas Behn; Victor Piotto; Carl A Coelho, PhD, BC-ANCDS
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session discusses a study that examined the feasibility of telehealth administration of narrative and procedural discourse tasks to individuals with TBI and matched controls. Results support the feasibility of collecting discourse samples via telehealth. Although the participants' discourse performance distinguished the TBI and control groups on the narrative task, no differences between the groups were noted for the procedural task.
Presenter(s): Catherine Wiseman-Hakes, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is a high prevalence of brain injury among youth and adults in the criminal justice system. The cognitive-communication impairments associated with brain injury can be a risk factor for both justice involvement and recidivism as well as barrier to successful community reintegration. This session focuses on the emerging role of SLPs with this underserved population, which may include assessment and intervention but may also include advocacy as well as training and education of front-line staff and justice professionals.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
<< 1 2 > >>